Very quick Google search throws up studies showing that biotechs are historically inversely related to interest rates
https://www.vetr.com/posts/5644714961-Biotech-ETFs-Bring-on-Rising-Rates
If you want to beat money in the bank you need a growth stock
But there may be other brokers to the contrary. Obviously borrowing is more expensive
SRX in any event can always be treated as an income earning share rather than a blue sky hope
Destined to fail, page-70
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.8¢ |
Change
0.003(1.43%) |
Mkt cap ! $75.34M | |||
| Open | High | Low | Value | Volume |
| 17.8¢ | 17.8¢ | 17.5¢ | $9.047K | 50.98K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 7293686 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 1399496 | 11 |
View Market Depth
| Last trade - 15.01pm 26/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |